2003
DOI: 10.1016/s1262-3636(07)70063-0
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence and cost of diabetes in metropolitan France: what trends between 1998 and 2000?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
13
0
4

Year Published

2004
2004
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(20 citation statements)
references
References 13 publications
3
13
0
4
Order By: Relevance
“…In 1999, 6.6 billion euro represented about 3.7% of the total expenditures that the French social protection system devoted to the ageing-survival risk (177 billion) and about 15% of the social expenditures (44 billion, including health care) dedicated to the compensation of elderly dependence and population impairments (although impaired population was not considered in our paper). In 1999 also, the medical cost of obesity treatment was 1.4 billion euro in France [48], the cost of diabetes for health insurance 5 billion [49], severe hypertension 5.5 billion [50] and last, cancer 11 billion [51].…”
Section: Economic Valuation Of Carementioning
confidence: 99%
“…In 1999, 6.6 billion euro represented about 3.7% of the total expenditures that the French social protection system devoted to the ageing-survival risk (177 billion) and about 15% of the social expenditures (44 billion, including health care) dedicated to the compensation of elderly dependence and population impairments (although impaired population was not considered in our paper). In 1999 also, the medical cost of obesity treatment was 1.4 billion euro in France [48], the cost of diabetes for health insurance 5 billion [49], severe hypertension 5.5 billion [50] and last, cancer 11 billion [51].…”
Section: Economic Valuation Of Carementioning
confidence: 99%
“…Data from the United States and Europe indicate that the health care expenditure for patients with diabetes mellitus is significantly higher than for comparable patients without this disease [1][2][3][4][5]. These and other studies [6][7][8][9] also suggest that the majority of such 'excess' costs can be attributed to diabetes-related complications.…”
Section: Introductionmentioning
confidence: 97%
“…Plusieurs auteurs soulignent le lien entre prévalence du diabète et facteurs socio-économiques en France par le biais notamment d'une augmentation de l'obésité, d'une diminution de l'activité physique [13][14][15][16][17][18][19] patients présentaient une RD contre seulement 22 % dans le reste de la population [20]. L'analyse des paramètres socioculturels pourrait donc permettre d'expliquer les résultats observés dans notre population qui présente d'une part un plus faible niveau socio-économique, ainsi qu'un taux plus élevé de personnes en situation de précarité [21].…”
Section: Discussionunclassified